These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19297632)

  • 41. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between childhood attention-deficit-hyperactivity symptoms and adulthood dissociation in male inmates: preliminary report.
    Matsumoto T; Imamura F
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):444-6. PubMed ID: 17610673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
    Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C
    J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is ADHD a growth industry?
    Goldstein S
    J Atten Disord; 2006 Feb; 9(3):461-4. PubMed ID: 16481662
    [No Abstract]   [Full Text] [Related]  

  • 45. Is ADHD a valid diagnosis in adults? No.
    Moncrieff J; Timimi S
    BMJ; 2010 Mar; 340():c547. PubMed ID: 20348183
    [No Abstract]   [Full Text] [Related]  

  • 46. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 47. What exactly are the benefits of stimulants for ADHD?
    Advokat C
    J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518
    [No Abstract]   [Full Text] [Related]  

  • 48. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.
    Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M
    Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case of a 67-year-old woman diagnosed with ADHD successfully treated with methylphenidate.
    da Silva MA; Louza M
    J Atten Disord; 2008 May; 11(6):623. PubMed ID: 18417727
    [No Abstract]   [Full Text] [Related]  

  • 51. Adult ADHD research: current status and future directions.
    Ramsay JR; Rostain AL
    J Atten Disord; 2008 May; 11(6):624-7. PubMed ID: 18417728
    [No Abstract]   [Full Text] [Related]  

  • 52. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The misuse and diversion of prescribed ADHD medications by college students.
    Rabiner DL; Anastopoulos AD; Costello EJ; Hoyle RH; McCabe SE; Swartzwelder HS
    J Atten Disord; 2009 Sep; 13(2):144-53. PubMed ID: 19448150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attention deficit hyperactivity disorder in a Canadian prison population.
    Usher AM; Stewart LA; Wilton G
    Int J Law Psychiatry; 2013; 36(3-4):311-5. PubMed ID: 23639768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attention deficit hyperactivity disorder in offenders and the need for early intervention.
    Belcher JR
    Int J Offender Ther Comp Criminol; 2014 Jan; 58(1):27-40. PubMed ID: 23222217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive performance enhancement: misuse or self-treatment?
    Peterkin AL; Crone CC; Sheridan MJ; Wise TN
    J Atten Disord; 2011 May; 15(4):263-8. PubMed ID: 20410324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.
    Dopheide JA
    Am J Manag Care; 2009 May; 15(5 Suppl):S141-50. PubMed ID: 19601689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADHD treatment and the risk of substance abuse.
    Sircy RA; Stojanoski A
    Nurse Pract; 2008 Apr; 33(4):33-6. PubMed ID: 18388552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.